Bliss GVS Pharma
BLISSGVS.NS
#8262
Rank
$0.15 B
Marketcap
$1.47
Share price
-1.92%
Change (1 day)
45.54%
Change (1 year)

Operating Margin for Bliss GVS Pharma (BLISSGVS.NS)

Operating Margin as of October 2024 (TTM): 16.56%

According to Bliss GVS Pharma's latest financial reports and stock price the company's current Operating Margin is 16.56%. At the end of 2023 the company had an Operating Margin of 14.19%.

Operating Margin history for Bliss GVS Pharma from 2013 to 2024

Operating Margin at the end of each year

Year Operating Margin Change
202314.19%93.34%
20227.34%-59.91%
202118.31%-3.18%
202018.91%-7.84%
201920.52%16.67%
201817.59%-24.52%
201723.30%-14%
201627.10%14.9%
201523.58%15.2%
201420.47%-25.83%
201327.60%-7.18%
201229.74%22.83%
201124.21%-10.64%
201027.09%-10.51%
200930.28%-12.01%
200834.41%265.8%
20079.41%

What is a company's Operating Margin?

The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.